3-n-butylphthalide has been researched along with Brain Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, ZX; Luo, H; Rong, BB; Wang, FT; Xu, XM; Zhang, SJ; Zheng, XM | 1 |
| Chen, Y; Guo, Y; Li, G; Li, W; Zhang, J | 1 |
| Cui, H; Liang, Z; Liu, Y; Shao, F; Shi, X; Tang, Z; Wu, Y; Yang, S; Yang, Z; Yu, C; Zhao, S | 1 |
| Jiang, C; Li, Y; Pang, J; Wang, B; Xiang, W; Xue, H; Zhang, J | 1 |
| Li, Y; Liu, Q; Wang, H; Wu, Q; Xu, C | 1 |
1 review(s) available for 3-n-butylphthalide and Brain Diseases
| Article | Year |
|---|---|
Management of delayed encephalopathy after CO poisoning: An evidence-based narrative review.
Topics: Benzofurans; Brain Diseases; Carbon Monoxide Poisoning; Dexamethasone; Drugs, Chinese Herbal; Humans; Hyperbaric Oxygenation; Mesenchymal Stem Cell Transplantation; Randomized Controlled Trials as Topic; Time Factors | 2019 |
2 trial(s) available for 3-n-butylphthalide and Brain Diseases
| Article | Year |
|---|---|
Efficacy of N-Butylphthalide and Hyperbaric Oxygen Therapy on Cognitive Dysfunction in Patients with Delayed Encephalopathy After Acute Carbon Monoxide Poisoning.
Topics: Acute Disease; Benzofurans; Brain Diseases; Carbon Monoxide Poisoning; Cognitive Dysfunction; Demography; Female; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Neuropsychological Tests; Remission Induction; Treatment Outcome | 2017 |
Combination of butylphthalide with umbilical mesenchymal stem cells for the treatment of delayed encephalopathy after carbon monoxide poisoning.
Topics: Adult; Analysis of Variance; Benzofurans; Brain Diseases; Carbon Monoxide Poisoning; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Mesenchymal Stem Cell Transplantation; Middle Aged; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
2 other study(ies) available for 3-n-butylphthalide and Brain Diseases
| Article | Year |
|---|---|
The Efficacy of N-Butylphthalide and Dexamethasone Combined with Hyperbaric Oxygen on Delayed Encephalopathy After Acute Carbon Monoxide Poisoning.
Topics: Activities of Daily Living; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Benzofurans; Brain Diseases; Carbon Monoxide Poisoning; Combined Modality Therapy; Dexamethasone; Female; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Young Adult | 2020 |
DL-3-n-butylphthalide-induced neuroprotection in rat models of asphyxia-induced cardiac arrest followed by cardiopulmonary resuscitation.
Topics: Animals; Apoptosis; Asphyxia; Benzofurans; Brain Diseases; Cardiopulmonary Resuscitation; Disease Models, Animal; Heart Arrest; Hippocampus; JNK Mitogen-Activated Protein Kinases; Neurons; Neuroprotection; Neuroprotective Agents; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats, Sprague-Dawley; Return of Spontaneous Circulation; Signal Transduction; tau Proteins; Time Factors | 2021 |